Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety, PK, PD and Food Effect of AZD7986 in Healthy Volunteers
NCT02303574Phase 1Completed
- Sponsor
- AstraZeneca
- Start
- Dec 2014
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial in bronchiectasis comparing AZD7986 with Placebo (2 arms). Primary endpoints: Number of Adverse Events (AEs), Area Under the Plasma Concentration Versus Time Curve from Time Zero to Last Quantifiable Concentration at Day 28 and 4 more. Started Dec 2014; status: completed.
02
Drugs
brensocatib
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on NCT02303574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02303574.